Dow Jones

40,211.72

0.53%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Adamis Pharmaceuticals Corporation (ADMP)
Adamis Pharmaceuticals Corporation (ADMP) Noticias

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ADMP

<< Anterior 1 2 3 4 5 6 7 8 9 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
05/08/2019	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Schedules Second Quarter 2019 Earnings Conference Call and Business Update	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
01/08/2019	16:20	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
01/08/2019	16:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
01/08/2019	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
31/07/2019	15:05	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
30/07/2019	05:03	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
24/07/2019	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Provides Update on Litigation with Belcher Pharmaceuticals	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
18/07/2019	12:52	GlobeNewswire Inc.	Adamis Pharmaceuticals Provides Update on Litigation with kaléo Inc.	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
09/07/2019	07:30	GlobeNewswire Inc.	Adamis Pharmaceuticals Provides Update on U.S. Retail Launch of SYMJEPI	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
25/06/2019	15:34	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
11/06/2019	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Provides Update on Its Higher Dose Naloxone Injection Product	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
29/05/2019	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals to Present at Conferences in June 2019	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
28/05/2019	17:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
21/05/2019	07:30	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces Patent Litigation Regarding Its Higher Dose Naloxone Injection Product	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
14/05/2019	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces Conditional Acceptance by FDA of Proprietary Name for Higher Dose Naloxone Product	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
09/05/2019	15:30	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
09/05/2019	15:27	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
07/05/2019	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
30/04/2019	16:02	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
15/03/2019	15:39	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces 2018 Financial Results and Provides Business Update	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
15/03/2019	15:24	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
14/03/2019	15:55	Business Wire	Adamis Pharmaceuticals Announces FDA Acceptance for Review of the New Drug Application of Its Higher Dose Naloxone Injection ...	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
12/03/2019	15:13	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
26/02/2019	17:54	GlobeNewswire Inc.	Adamis Provides Regulatory Update on Sublingual Tadalafil	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
20/02/2019	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Publishes the Rationale for a Higher Dose Naloxone Product to Counter the Current Opioid Epidemic	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
12/02/2019	17:47	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
11/02/2019	09:28	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
25/01/2019	16:08	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
16/01/2019	15:18	GlobeNewswire Inc.	Adamis’ Commercial Partner Launches SYMJEPI™ (epinephrine) in the US	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
31/12/2018	15:02	GlobeNewswire Inc.	Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled Syringe	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation